RECURSION PHARMACEUTICALS INC. - CLASS A COMMON S

Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8

03 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry

20 дек 2023 06:59:00 Источник Nasdaq GlobeNewswire

Bayer and Recursion Focus Research Collaboration on Oncology

09 ноя 2023 08:41:30 Источник Nasdaq GlobeNewswire

Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology

09 ноя 2023 07:01:00 Источник Nasdaq GlobeNewswire

Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results

09 ноя 2023 06:58:00 Источник Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conference

02 ноя 2023 07:05:00 Источник Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

05 сен 2023 15:30:00 Источник Nasdaq GlobeNewswire

Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

05 сен 2023 06:59:00 Источник Nasdaq GlobeNewswire

Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

08 авг 2023 07:00:01 Источник Nasdaq GlobeNewswire

Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results

08 авг 2023 06:58:00 Источник Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conference

01 авг 2023 07:30:00 Источник Nasdaq GlobeNewswire

Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

26 июл 2023 17:58:00 Источник Nasdaq GlobeNewswire

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

12 июл 2023 07:30:00 Источник Nasdaq GlobeNewswire

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

26 июн 2023 10:48:04 Источник Nasdaq GlobeNewswire

Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

13 июн 2023 07:00:01 Источник Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

01 июн 2023 07:30:00 Источник Nasdaq GlobeNewswire

Altitude Lab Relocates to Gateway’s BioHive Hub

25 май 2023 15:00:00 Источник Nasdaq GlobeNewswire

Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results

08 май 2023 07:14:39 Источник Nasdaq GlobeNewswire

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

08 май 2023 06:59:00 Источник Nasdaq GlobeNewswire